osimertinib
astrazeneca
['flaura']
 many of those patients got 1st gen egfri which while not ideal by any means,per flaura they re still getting 80% of the benefit. my biggest question isn t if but how much i don t think 3y duration of osi for everyone makes a ton of sense and i think we need mrd to personalize
Professor, Medical Oncology @UCSD; PI @Patel_Lab computational immunopathology; Phase 1 & thoracic/NSCLC immunotherapy, solid tumor cell therapy, irAEs (he/him)